This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shams, I.
Right arrow Articles by Lax, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shams, I.
Right arrow Articles by Lax, I.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 2007, p. 6903-6912, Vol. 27, No. 19
0270-7306/07/$08.00+0     doi:10.1128/MCB.00544-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Lacrimo-Auriculo-Dento-Digital Syndrome Is Caused by Reduced Activity of the Fibroblast Growth Factor 10 (FGF10)-FGF Receptor 2 Signaling Pathway{triangledown}

Imad Shams,1 Edyta Rohmann,2,3 Veraragavan P. Eswarakumar,1 Erin D. Lew,1 Satoru Yuzawa,1 Bernd Wollnik,2,3 Joseph Schlessinger,1 and Irit Lax1*

Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520,1 Center for Molecular Medicine Cologne,2 Institute of Human Genetics, University of Cologne, Cologne, Germany3

Received 28 March 2007/ Returned for modification 14 May 2007/ Accepted 24 July 2007

Lacrimo-auriculo-dento-digital (LADD) syndrome is characterized by abnormalities in lacrimal and salivary glands, in teeth, and in the distal limbs. Genetic studies have implicated heterozygous mutations in fibroblast growth factor 10 (FGF10) and in FGF receptor 2 (FGFR2) in LADD syndrome. However, it is not clear whether LADD syndrome mutations (LADD mutations) are gain- or loss-of-function mutations. In order to reveal the molecular mechanism underlying LADD syndrome, we have compared the biological properties of FGF10 LADD and FGFR2 LADD mutants to the activities of their normal counterparts. These experiments show that the biological activities of three different FGF10 LADD mutants are severely impaired by different mechanisms. Moreover, haploinsufficiency caused by defective FGF10 mutants leads to LADD syndrome. We also demonstrate that the tyrosine kinase activities of FGFR2 LADD mutants expressed in transfected cells are strongly compromised. Since tyrosine kinase activity is stimulated by ligand-induced receptor dimerization, FGFR2 LADD mutants may also exert a dominant inhibitory effect on signaling via wild-type FGFR2 expressed in the same cell. These experiments underscore the importance of signal strength in mediating biological responses and that relatively small changes in receptor signaling may influence the outcome of developmental processes in cells or organs that do not possess redundant signaling pathway.

* Corresponding author. Mailing address: Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, SHM B-295, New Haven, CT 06520. Phone: (203) 785-7395. Fax: (203) 785-3879. E-mail: Irit.lax{at}yale.edu

{triangledown} Published ahead of print on 6 August 2007.

Molecular and Cellular Biology, October 2007, p. 6903-6912, Vol. 27, No. 19
0270-7306/07/$08.00+0     doi:10.1128/MCB.00544-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Makarenkova, H. P., Hoffman, M. P., Beenken, A., Eliseenkova, A. V., Meech, R., Tsau, C., Patel, V. N., Lang, R. A., Mohammadi, M. (2009). Differential Interactions of FGFs with Heparan Sulfate Control Gradient Formation and Branching Morphogenesis. Sci Signal 2: ra55-ra55 [Abstract] [Full Text]  
  • Gartside, M. G., Chen, H., Ibrahimi, O. A., Byron, S. A., Curtis, A. V., Wellens, C. L., Bengston, A., Yudt, L. M., Eliseenkova, A. V., Ma, J., Curtin, J. A., Hyder, P., Harper, U. L., Riedesel, E., Mann, G. J., Trent, J. M., Bastian, B. C., Meltzer, P. S., Mohammadi, M., Pollock, P. M. (2009). Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma. Mol Cancer Res 7: 41-54 [Abstract] [Full Text]  
  • Lew, E. D., Bae, J. H., Rohmann, E., Wollnik, B., Schlessinger, J. (2007). Structural basis for reduced FGFR2 activity in LADD syndrome: Implications for FGFR autoinhibition and activation. Proc. Natl. Acad. Sci. USA 104: 19802-19807 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»